The Bcl-3 oncogene was first identified in a subset of patients with chronic lymphocytic leukemia (CLL) in the region adjacent to the t(14;19)(q32;q13) translocation [1,2]. The gene discussed is BCL3; the disease is B-cell chronic lymphocytic leukemia.